Market Cap 4.45B
Revenue (ttm) 1.39B
Net Income (ttm) -242.47M
EPS (ttm) N/A
PE Ratio 22.25
Forward PE 21.16
Profit Margin -17.47%
Debt to Equity Ratio 0.22
Volume 440,211
Avg Vol 720,302
Day's Range N/A - N/A
Shares Out 55.09M
Stochastic %K 41%
Beta 0.86
Analysts Strong Sell
Price Target $87.27

Company Profile

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an...

Industry: Medical Devices
Sector: Healthcare
Phone: 44 1452 638 500
Fax: 44 1452 638 530
Address:
5220 Valiant Court, Gloucester Business Park, Gloucester, United Kingdom
mru01
mru01 Aug. 5 at 4:55 PM
$LIVN great results. Why is it dropping?
0 · Reply
EarningsInsider
EarningsInsider Aug. 5 at 1:32 PM
https://www.marketbeat.com/earnings/reports/2026-8-5-livanova-plc-stock/ $LIVN LivaNova Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 5 at 11:57 AM
$LIVN Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $1.98 up 296.00% YoY • Reported revenue of $390.6M up 10.81% YoY • LivaNova now expects full-year 2026 revenue to grow between 8% and 9% on a constant-currency basis and adjusted diluted earnings per share in the range of $4.30 to $4.40.
0 · Reply
Wigglyick
Wigglyick Jun. 28 at 4:46 PM
$LIVN Livanova - A medical technology company that sells products for Cardiopulmonary & Neuromodulation. Only 380 watchers on ST. Last ER was a beat. 4.5B MC & smallish float.
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 3 at 4:14 AM
$LIVN Share Price: $73.35 Contract Selected: Dec 18, 2026 $70 Calls Buy Zone: $9.35 – $11.55 Target Zone: $17.22 – $21.04 Potential Upside: 74% ROI Time to Expiration: 198 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
PrimeZoneNews
PrimeZoneNews May. 27 at 3:34 PM
$VVOS $LIVN As you can see under the section "Other Players": These are the only companies listed on Nasdaq. LIVN has a market cap of $4B, and VVOS has a market cap of $10M. https://www.marketsandmarkets.com/Market-Reports/united-states-sleep-apnea-devices-market-220821026.html
1 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 4:54 PM
$LIVN Current Stock Price: $70.43 Contracts to trade: $70.0 LIVN May 15 2026 Call Entry: $1.25 Exit: $1.79 ROI: 43% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SmartMoneyTradez
SmartMoneyTradez May. 7 at 7:33 PM
0 · Reply
Mogeyman
Mogeyman May. 7 at 6:30 PM
0 · Reply
The_Gambl3r
The_Gambl3r May. 7 at 3:09 AM
$LIVN $MDT $FMS $BAX $NUWE ** 👀👀
1 · Reply
Latest News on LIVN
LivaNova selloff brings attractive entry point, says Mizuho

2026-08-21T11:20:21.000Z - 9 hours ago

LivaNova selloff brings attractive entry point, says Mizuho


LivaNova price target raised to $85 from $80 at Stifel

2026-08-05T18:01:32.000Z - 16 days ago

LivaNova price target raised to $85 from $80 at Stifel


LivaNova price target raised to $93 from $81 at Needham

2026-08-05T17:15:23.000Z - 16 days ago

LivaNova price target raised to $93 from $81 at Needham


LivaNova Earnings Call Transcript: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 16 days ago

LivaNova Earnings Call Transcript: Q2 2026


LivaNova Earnings release: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 16 days ago

LivaNova Earnings release: Q2 2026


LivaNova Slides: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 16 days ago

LivaNova Slides: Q2 2026


LivaNova Quarterly report: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 16 days ago

LivaNova Quarterly report: Q2 2026


LivaNova reports Q2 adjusted EPS $1.26, consensus $1.09

2026-08-05T10:10:36.000Z - 16 days ago

LivaNova reports Q2 adjusted EPS $1.26, consensus $1.09


LivaNova price target raised to $95 from $90 at Mizuho

2026-07-15T11:32:07.000Z - 5 weeks ago

LivaNova price target raised to $95 from $90 at Mizuho


LivaNova initiated with a Hold at Freedom Capital

2026-06-30T20:25:40.000Z - 7 weeks ago

LivaNova initiated with a Hold at Freedom Capital


LivaNova to Announce Second-Quarter 2026 Results

Jun 24, 2026, 9:00 AM EDT - 2 months ago

LivaNova to Announce Second-Quarter 2026 Results


LivaNova price target raised to $92 from $83 at KeyBanc

2026-06-22T09:45:05.000Z - 2 months ago

LivaNova price target raised to $92 from $83 at KeyBanc


Jette Nygaard-Andersen Joins LivaNova Board as a New Director

Jun 11, 2026, 1:44 PM EDT - 2 months ago

Jette Nygaard-Andersen Joins LivaNova Board as a New Director


LivaNova Transcript: AGM 2026

Jun 10, 2026, 10:00 AM EDT - 2 months ago

LivaNova Transcript: AGM 2026


LivaNova appoints Liddy as Chief Legal Officer

2026-06-05T13:05:33.000Z - 2 months ago

LivaNova appoints Liddy as Chief Legal Officer


LivaNova Appoints Anne Liddy as Chief Legal Officer

Jun 5, 2026, 9:00 AM EDT - 2 months ago

LivaNova Appoints Anne Liddy as Chief Legal Officer


LivaNova appoints Stefano Folli as President, Cardiopulmonary

2026-05-21T13:39:56.000Z - 3 months ago

LivaNova appoints Stefano Folli as President, Cardiopulmonary


LivaNova price target lowered to $76 from $78 at Baird

2026-05-07T15:51:44.000Z - 3 months ago

LivaNova price target lowered to $76 from $78 at Baird


LivaNova price target raised to $90 from $85 at Mizuho

2026-05-07T15:50:20.000Z - 3 months ago

LivaNova price target raised to $90 from $85 at Mizuho


LivaNova price target raised to $76 from $73 at Barclays

2026-05-07T11:56:34.000Z - 3 months ago

LivaNova price target raised to $76 from $73 at Barclays


LivaNova reports Q1 adjusted EPS 98c, consensus 90c

2026-05-07T09:56:32.000Z - 3 months ago

LivaNova reports Q1 adjusted EPS 98c, consensus 90c


LivaNova Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

LivaNova Earnings Call Transcript: Q1 2026


LivaNova Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

LivaNova Earnings release: Q1 2026


LivaNova Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

LivaNova Slides: Q1 2026


LivaNova Quarterly report: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

LivaNova Quarterly report: Q1 2026


LivaNova Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

LivaNova Proxy statement: Proxy filing


LivaNova Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

LivaNova Proxy statement: Proxy filing


LivaNova to Announce First-Quarter 2026 Results

Mar 25, 2026, 9:00 AM EDT - 5 months ago

LivaNova to Announce First-Quarter 2026 Results


LivaNova granted premarket approval for aura6000 System by FDA

2026-03-19T12:42:05.000Z - 5 months ago

LivaNova granted premarket approval for aura6000 System by FDA


LivaNova price target raised to $73 from $67 at Barclays

2026-02-27T10:40:15.000Z - 6 months ago

LivaNova price target raised to $73 from $67 at Barclays


LivaNova Earnings Call Transcript: Q4 2025

Feb 25, 2026, 8:00 AM EST - 6 months ago

LivaNova Earnings Call Transcript: Q4 2025


LivaNova Annual report: Q4 2025

Feb 25, 2026, 8:00 AM EST - 6 months ago

LivaNova Annual report: Q4 2025


LivaNova Earnings release: Q4 2025

Feb 25, 2026, 8:00 AM EST - 6 months ago

LivaNova Earnings release: Q4 2025


LivaNova Slides: Q4 2025

Feb 25, 2026, 8:00 AM EST - 6 months ago

LivaNova Slides: Q4 2025


LivaNova Annual report: Q4 2025

Feb 25, 2026, 8:00 AM EST - 6 months ago

LivaNova Annual report: Q4 2025


LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results

Jan 20, 2026, 9:00 AM EST - 7 months ago

LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results


LivaNova Transcript: Wolfe Research Healthcare Conference 2025

Nov 17, 2025, 2:40 PM EST - 9 months ago

LivaNova Transcript: Wolfe Research Healthcare Conference 2025


LivaNova Transcript: Investor Day 2025

Nov 12, 2025, 9:00 AM EST - 10 months ago

LivaNova Transcript: Investor Day 2025


LivaNova Slides: FY 2025

Nov 12, 2025, 9:00 AM EST - 10 months ago

LivaNova Slides: FY 2025


LivaNova Earnings Call Transcript: Q3 2025

Nov 5, 2025, 8:00 AM EST - 10 months ago

LivaNova Earnings Call Transcript: Q3 2025


LivaNova Quarterly report: Q3 2025

Nov 5, 2025, 8:00 AM EST - 10 months ago

LivaNova Quarterly report: Q3 2025


LivaNova Earnings release: Q3 2025

Nov 5, 2025, 8:00 AM EST - 10 months ago

LivaNova Earnings release: Q3 2025


LivaNova Slides: Q3 2025

Nov 5, 2025, 8:00 AM EST - 10 months ago

LivaNova Slides: Q3 2025


LivaNova to Announce Third-Quarter 2025 Results

Oct 8, 2025, 9:00 AM EDT - 11 months ago

LivaNova to Announce Third-Quarter 2025 Results


LivaNova Transcript: Baird Global Healthcare Conference 2025

Sep 9, 2025, 3:45 PM EDT - 1 year ago

LivaNova Transcript: Baird Global Healthcare Conference 2025


LivaNova Appoints Donald Zurbay as a New Director

Sep 4, 2025, 9:00 AM EDT - 1 year ago

LivaNova Appoints Donald Zurbay as a New Director


LivaNova to Host Investor Day on November 12, 2025

Aug 25, 2025, 9:00 AM EDT - 1 year ago

LivaNova to Host Investor Day on November 12, 2025


LivaNova Launches Essenz Perfusion System in China

Aug 18, 2025, 9:00 AM EDT - 1 year ago

LivaNova Launches Essenz Perfusion System in China


LivaNova Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 1 year ago

LivaNova Earnings Call Transcript: Q2 2025


LivaNova Quarterly report: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 1 year ago

LivaNova Quarterly report: Q2 2025


LivaNova Earnings release: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 1 year ago

LivaNova Earnings release: Q2 2025


LivaNova Slides: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 1 year ago

LivaNova Slides: Q2 2025


LivaNova to Announce Second-Quarter 2025 Results

Jul 9, 2025, 9:00 AM EDT - 1 year ago

LivaNova to Announce Second-Quarter 2025 Results


LivaNova Transcript: AGM 2025

Jun 11, 2025, 10:00 AM EDT - 1 year ago

LivaNova Transcript: AGM 2025


LivaNova Earnings Call Transcript: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

LivaNova Earnings Call Transcript: Q1 2025


LivaNova Quarterly report: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

LivaNova Quarterly report: Q1 2025


LivaNova Earnings release: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

LivaNova Earnings release: Q1 2025


LivaNova Slides: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

LivaNova Slides: Q1 2025


LivaNova Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

LivaNova Proxy statement: Proxy Filing


LivaNova Proxy statement: Proxy Filing

Apr 30, 2025, 8:00 AM EDT - 1 year ago

LivaNova Proxy statement: Proxy Filing


LivaNova to Announce First-Quarter 2025 Results

Mar 26, 2025, 8:00 AM EDT - 1 year ago

LivaNova to Announce First-Quarter 2025 Results


LivaNova Earnings Call Transcript: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

LivaNova Earnings Call Transcript: Q4 2024


LivaNova Annual report: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

LivaNova Annual report: Q4 2024


LivaNova Earnings release: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

LivaNova Earnings release: Q4 2024


LivaNova Slides: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

LivaNova Slides: Q4 2024


LivaNova Transcript: Stifel 2024 Healthcare Conference

Nov 19, 2024, 11:30 AM EST - 1 year ago

LivaNova Transcript: Stifel 2024 Healthcare Conference


LivaNova Earnings Call Transcript: Q3 2024

Oct 30, 2024, 8:00 AM EDT - 1 year ago

LivaNova Earnings Call Transcript: Q3 2024


LivaNova Quarterly report: Q3 2024

Oct 30, 2024, 8:00 AM EDT - 1 year ago

LivaNova Quarterly report: Q3 2024


LivaNova Earnings release: Q3 2024

Oct 30, 2024, 8:00 AM EDT - 1 year ago

LivaNova Earnings release: Q3 2024


LivaNova Slides: Q3 2024

Oct 30, 2024, 8:00 AM EDT - 1 year ago

LivaNova Slides: Q3 2024


LivaNova Reports Third-Quarter 2024 Results

Oct 30, 2024, 6:00 AM EDT - 1 year ago

LivaNova Reports Third-Quarter 2024 Results


LivaNova Appoints Susan Podlogar as a New Director

Oct 8, 2024, 9:00 AM EDT - 2 years ago

LivaNova Appoints Susan Podlogar as a New Director


LivaNova to Announce Third-Quarter 2024 Results

Sep 25, 2024, 9:00 AM EDT - 2 years ago

LivaNova to Announce Third-Quarter 2024 Results


LivaNova Transcript: Baird 2024 Global Healthcare Conference

Sep 10, 2024, 10:15 AM EDT - 2 years ago

LivaNova Transcript: Baird 2024 Global Healthcare Conference


LivaNova to Present at the Baird Global Healthcare Conference

Aug 19, 2024, 9:00 AM EDT - 2 years ago

LivaNova to Present at the Baird Global Healthcare Conference


LivaNova Earnings Call Transcript: Q2 2024

Jul 31, 2024, 8:00 AM EDT - 2 years ago

LivaNova Earnings Call Transcript: Q2 2024


LivaNova Quarterly report: Q2 2024

Jul 31, 2024, 8:00 AM EDT - 2 years ago

LivaNova Quarterly report: Q2 2024


LivaNova Earnings release: Q2 2024

Jul 31, 2024, 8:00 AM EDT - 2 years ago

LivaNova Earnings release: Q2 2024


LivaNova Slides: Q2 2024

Jul 31, 2024, 8:00 AM EDT - 2 years ago

LivaNova Slides: Q2 2024


LivaNova Reports Second-Quarter 2024 Results

Jul 31, 2024, 6:00 AM EDT - 2 years ago

LivaNova Reports Second-Quarter 2024 Results


mru01
mru01 Aug. 5 at 4:55 PM
$LIVN great results. Why is it dropping?
0 · Reply
EarningsInsider
EarningsInsider Aug. 5 at 1:32 PM
https://www.marketbeat.com/earnings/reports/2026-8-5-livanova-plc-stock/ $LIVN LivaNova Earnings Transcript
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 5 at 11:57 AM
$LIVN Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $1.98 up 296.00% YoY • Reported revenue of $390.6M up 10.81% YoY • LivaNova now expects full-year 2026 revenue to grow between 8% and 9% on a constant-currency basis and adjusted diluted earnings per share in the range of $4.30 to $4.40.
0 · Reply
Wigglyick
Wigglyick Jun. 28 at 4:46 PM
$LIVN Livanova - A medical technology company that sells products for Cardiopulmonary & Neuromodulation. Only 380 watchers on ST. Last ER was a beat. 4.5B MC & smallish float.
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 3 at 4:14 AM
$LIVN Share Price: $73.35 Contract Selected: Dec 18, 2026 $70 Calls Buy Zone: $9.35 – $11.55 Target Zone: $17.22 – $21.04 Potential Upside: 74% ROI Time to Expiration: 198 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
PrimeZoneNews
PrimeZoneNews May. 27 at 3:34 PM
$VVOS $LIVN As you can see under the section "Other Players": These are the only companies listed on Nasdaq. LIVN has a market cap of $4B, and VVOS has a market cap of $10M. https://www.marketsandmarkets.com/Market-Reports/united-states-sleep-apnea-devices-market-220821026.html
1 · Reply
BillionerOfKing
BillionerOfKing May. 11 at 4:54 PM
$LIVN Current Stock Price: $70.43 Contracts to trade: $70.0 LIVN May 15 2026 Call Entry: $1.25 Exit: $1.79 ROI: 43% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SmartMoneyTradez
SmartMoneyTradez May. 7 at 7:33 PM
0 · Reply
Mogeyman
Mogeyman May. 7 at 6:30 PM
0 · Reply
The_Gambl3r
The_Gambl3r May. 7 at 3:09 AM
$LIVN $MDT $FMS $BAX $NUWE ** 👀👀
1 · Reply
Estimize
Estimize May. 6 at 10:06 PM
$LIVN reported 0.98 EPS and 263.30 revenue for Q1. http://www.estimize.com/intro/livn?chart=historical&metric_name=eps&utm_content=LIVN&utm
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 6 at 10:17 AM
$LIVN Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.41 up 106.82% YoY • Reported revenue of $362.3M up 14.34% YoY • LivaNova raised its full-year 2026 constant-currency revenue growth guidance to 7.0% to 8.0% and adjusted diluted EPS to $4.20 to $4.30, while maintaining adjusted free cash flow guidance at $160M to $180M.
0 · Reply
Estimize
Estimize May. 4 at 10:03 AM
Wall St is expecting 0.90 EPS for $LIVN Q1 [Reporting 05/06 BMO] http://www.estimize.com/intro/livn?chart=historical&metric_name=eps&utm_co
0 · Reply
BillionerOfKing
BillionerOfKing Mar. 3 at 2:37 AM
$LIVN Current Stock Price: $70.26 Contracts to trade: $70.0 LIVN Mar 20 2026 Call Entry: $0.95 Exit: $1.53 ROI: 61% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Estimize
Estimize Feb. 25 at 11:09 PM
$LIVN reported 0.86 EPS and 360.90 revenue for Q4. http://www.estimize.com/intro/livn?chart=historical&metric_name=eps&utm_content=LIVN&utm
0 · Reply
briefingcom
briefingcom Feb. 25 at 1:12 PM
$LIVN: LivaNova beats by $0.04, beats on revs; guides FY26 EPS above consensus, revs in-line https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260225061017LIVN&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 25 at 11:13 AM
$LIVN Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.57 down -44.66% YoY • Reported revenue of $360.9M up 12.15% YoY • LivaNova PLC expects full-year 2026 revenue to grow 6.0% to 7.0% on a constant-currency basis. Adjusted diluted earnings per share is projected between $4.15 and $4.25, with adjusted free cash flow in the $160 million to $180 million range.
0 · Reply